Check out your Company Bowl for anonymous work chats.
This #SarcoidosisAwarenessMonth we’re working with the Bernie Mac Foundation to help shine a light on a condition that disproportionately impacts the Black community. Sarcoisdosis is a rare inflammatory disease that currently has no cure and few treatments. We are currently working on a research study to try and better understand the genetics behind the condition.
Since the founding of 23andMe in 2006, we have helped unlock genetic information for more than 13 million customers. "We want to help people understand what makes them who they are,” shared Anne Wojcicki, our CEO and co-founder, in this article by Sequoia Capital. Check out the full article for an inside look at how 23andMe got started and the challenges we've faced along the way.
Our clinical results from the Phase 1 portion of our First-in-Human Phase 1/2a study showed 23ME-00610 demonstrated an acceptable safety and tolerability profile. These results will be presented at #AACR23. “The Phase 2a portion of the study is now underway and we look forward to further evaluation of 23ME-00610 in the trial’s expansion cohorts,” said Jennifer Low, MD, PhD, Head of Therapeutics Development at 23andMe. Please see our press release for more information.
Meet Jessica Christenson, our talented Customer Stories Producer who self-proclaims that she has one of the best and most fascinating jobs at 23andMe! As part of her role, Jess gets to talk to our amazing customers who have made life-changing discoveries thanks to their 23andMe reports. She works with customers to share and amplify their stories – inspiring others to take action and discover their own DNA findings. Jess has been with 23andMe for over five years and says that the best part of working here is the community and relationships she’s built with her colleagues. “Not only are my teammates incredibly smart and talented, but they are kind and supportive,” she says. “I’m truly grateful for the sense of family that 23andMe has given me, especially during the pandemic.”
This month’s Ancestry Composition update may provide more detail for customers with Indigenous American ancestry from the Caribbean. We have added 4 new Indigenous Caribbean Genetic Groups – Cuba, Puerto Rico, Dominican Republic, and Southern Caribbean, which may reflect genetic ancestry related to the Taíno people, Kalinago, or other groups who were Indigenous to the Caribbean. *This update is only for 23andMe customers on the latest genotyping platform, v5.
In collaboration with the Morehouse School of Medicine and Sickle Cell Foundation of Georgia, Inc., we are launching a Sickle Cell Carrier Status Awareness Program. This is the first such collaboration between a genetic testing company and a Historically Black Medical College (HBMC). We hope it will increase access to information on sickle cell carrier status, and offer resources to individuals with sickle cell trait and sickle cell disease.
According to the Parkinson's Foundation, every 6 minutes someone in the U.S. is diagnosed with Parkinson’s disease (PD), a neurodegenerative condition characterized by tremor, muscle stiffness, and problems with movement. Many factors can increase the risk of developing PD, including genetics, age, sex, family history, and exposure to certain chemicals. Learn more here: https://lnkd.in/gqPmJ29q #ParkinsonsAwarenessMonth #Take6forPD
Earlier this week we hosted a speaker series with Nathan Price, Chief Scientific Officer of Thorne HealthTech and author of The Age of Scientific Wellness. Nathan shared valuable insights into precision health strategies, personal genetics, and cutting-edge technological advancements for data gathering.
There’s nothing more personal than your DNA. Today and every day, we celebrate YOU.
Irritable bowel syndrome (IBS) is a disorder impacting the large intestine, causing a range of symptoms like abdominal pain, cramping, and bloating that can be severe enough to impact quality of life. By reducing the stigma around IBS, more people will receive the diagnosis and treatment they need to manage their symptoms. #IBSawarenessmonth #YouandIBS
